MedVellum
MedVellum
Back to Library
Gynaecology
General Practice
Reproductive Medicine

Adenomyosis

High EvidenceUpdated: 2025-12-25

On This Page

Red Flags

  • Post-Menopausal Bleeding (Endometrial Cancer)
  • Severe Anaemia (Hemodynamic Instability)
  • Acute Severe Pain (Ovarian Torsion/Ectopic)
Overview

Adenomyosis

1. Clinical Overview

Summary

Adenomyosis is a benign gynaecological condition where endometrial glands and stroma invade the myometrium (muscular wall of the uterus). It is essentially "endometriosis of the uterine muscle." This ectopic endometrial tissue undergoes cyclical bleeding with menstruation, causing the uterus to become enlarged, boggy, and tender (the classic "bulky uterus"). The condition typically affects multiparous women in their 40s-50s and presents with heavy menstrual bleeding (menorrhagia) and painful periods (dysmenorrhea). Unlike fibroids, adenomyosis causes diffuse, symmetrical uterine enlargement. Diagnosis has shifted from histological (post-hysterectomy) to imaging-based, with MRI (Junctional Zone >12mm) being the gold standard and transvaginal ultrasound increasingly accurate. Medical management includes the Mirena IUS (first-line), hormonal therapies, and NSAIDs. Hysterectomy is the only definitive cure. Adenomyosis often coexists with fibroids and endometriosis, complicating diagnosis and management. [1,2]

Clinical Pearls

"Boggy Uterus": On bimanual examination, the uterus feels soft, tender, and diffusely enlarged (Unlike fibroids which are firm and knobbly).

"Junctional Zone >12mm": The MRI hallmark of adenomyosis. The JZ is the inner myometrial layer.

Mirena is First-Line: Levonorgestrel IUS (Mirena) thins the endometrium and reduces both bleeding and pain.

Hysterectomy is the Only Cure: Medical management is symptomatic. If family complete and symptoms severe, hysterectomy is definitive.


2. Epidemiology

Demographics

FactorNotes
AgeLate reproductive years: 40-50 years.
ParityMore common in multiparous women (Have had children).
PrevalenceDifficult to estimate. Found in 20-35% of hysterectomy specimens.

Risk Factors

Risk FactorNotes
MultiparityMultiple pregnancies = Higher risk.
Prior Uterine SurgeryCaesarean section, D&C, Myomectomy – May disrupt the junctional zone.
Age >40Peak incidence in late reproductive years.
Early MenarcheProlonged oestrogen exposure.

Associated Conditions

  • Endometriosis (30-40% co-occurrence).
  • Uterine Fibroids (Leiomyomas).
  • Endometrial Polyps.

3. Pathophysiology

Anatomy

  • Junctional Zone (JZ): The inner third of the myometrium, immediately beneath the endometrium. Distinct on MRI.
  • Normal JZ: less than 8mm.
  • Adenomyosis: JZ >12mm (thickened by ectopic endometrial tissue).

Mechanism

  1. Endometrial Invasion: Endometrial glands and stroma invade into the myometrium (Possibly via disrupted JZ from surgery/trauma).
  2. Ectopic Tissue Response: Ectopic tissue responds to oestrogen/progesterone cycling.
  3. Cyclical Bleeding: Monthly bleeding within the myometrium causes local inflammation.
  4. Myometrial Hypertrophy: Reactive smooth muscle hypertrophy and oedema → Enlarged uterus.
  5. Pain and Bleeding: Inflammatory response causes dysmenorrhea. Enlarged vessel surface area causes menorrhagia.

Types

TypeDescription
Diffuse AdenomyosisScattered implants throughout the myometrium. Most common.
Focal Adenomyosis (Adenomyoma)Localised nodular mass mimicking a fibroid.

4. Differential Diagnosis
ConditionKey Features
AdenomyosisDiffuse/Boggy enlarged uterus, Dysmenorrhea, Menorrhagia, JZ >12mm on MRI.
Uterine Fibroids (Leiomyomas)Discrete, Firm, Knobbly masses. Asymmetrical enlargement. Well-defined on imaging.
Endometrial PolypsIntermenstrual bleeding. Seen on hysteroscopy/USS.
EndometriosisPelvic pain (Cyclical), Dyspareunia, Infertility. Extra-uterine disease.
Endometrial CancerPost-menopausal bleeding. Thickened endometrium on USS. Histological diagnosis.
Ovarian CystsAdnexal mass. Not uterine. USS characteristics.

Adenomyosis vs Fibroids

FeatureAdenomyosisFibroids
ConsistencySoft, BoggyFirm, Hard
EnlargementDiffuse, SymmetricalDiscrete masses, Asymmetrical
BordersIll-definedWell-defined
USSHeterogeneous myometrium, CystsHypoechoic, Circumscribed
MRIJZ thickeningWell-demarcated mass

5. Clinical Presentation

Symptoms

SymptomNotes
MenorrhagiaHeavy menstrual bleeding. Often flooding, Clots.
DysmenorrheaSevere period pain. Often described as "cramping" or "dragging".
Chronic Pelvic PainMay persist beyond menstruation.
DyspareuniaDeep pelvic pain during intercourse.
InfertilityPossible contribution (Disrupted uterine contractility/implantation).

Examination Findings

FindingNotes
Bimanual ExamEnlarged, Soft ("Boggy"), Tender uterus. Usually symmetrical (Unlike fibroids).
SpeculumMay appear normal.
SizeTypically 2-3x normal size (But can be subtle).

6. Investigations

Imaging

ModalityFindingsNotes
Transvaginal Ultrasound (TVUS)Heterogeneous ("Rain in the forest" appearance), Asymmetrical wall thickening, Myometrial cysts, Poorly defined endomyometrial junction, Subendometrial linear striations.Good sensitivity in experienced hands. First-line.
MRI PelvisJunctional Zone >12mm (Gold Standard finding), High signal foci on T2 (Ectopic endometrium/haemorrhage), Diffuse or focal myometrial involvement.Most accurate. Reserved for equivocal USS or surgical planning.
3D UltrasoundImproved JZ visualisation.Increasing use.

Other

  • Histology: Definitive diagnosis made on hysterectomy specimen (Shows endometrial glands >2.5mm from endomyometrial junction). No longer needed for diagnosis with good imaging.

7. Management

Management Algorithm

       SUSPECTED ADENOMYOSIS
       (Heavy painful periods, Bulky tender uterus)
                     ↓
       CONFIRM DIAGNOSIS
       - Transvaginal Ultrasound (First-line)
       - MRI Pelvis (If USS equivocal or surgical planning)
       - Exclude fibroids, polyps, cancer
                     ↓
       ASSESS PATIENT PRIORITIES
       - Fertility desire?
       - Severity of symptoms?
       - Age and proximity to menopause?
                     ↓
       MANAGEMENT OPTIONS
    ┌────────────────┴────────────────┐
 CONSERVATIVE                      INTERVENTIONAL/SURGICAL
 (Non-surgical)                       ↓
    ↓

Conservative/Medical Management

TreatmentNotes
Mirena IUS (Levonorgestrel)First-line. Thins endometrium and adenomyotic deposits. Highly effective for bleeding and pain. 5-year licence.
COCP (Combined Oral Contraceptive Pill)Suppresses ovulation. Thins endometrium. Continuous use avoids withdrawal bleeds.
ProgestogensOral (Norethisterone) or Depot (Depo-Provera). Reduces bleeding.
Tranexamic AcidAntifibrinolytic. Reduces bleeding on heavy days (Does not address pain).
NSAIDs (Mefenamic Acid)Reduces prostaglandin-mediated pain and bleeding.
GnRH Agonists (Goserelin)Induces temporary menopause. Shrinks uterus. Side effects limit long-term use. Bridge to surgery.

Interventional Options

TreatmentNotes
Uterine Artery Embolisation (UAE)Radiological occlusion of uterine arteries. Variable success for adenomyosis (Less effective than for fibroids).
Endometrial AblationCaution: Adenomyosis is DEEP in the muscle. Ablation only treats surface. Risk of trapped blood ("Haematometra") if JZ is destroyed but deep disease remains. Generally AVOIDED.
MRI-Guided Focused Ultrasound (MRgFUS)Thermal ablation. Experimental for adenomyosis.

Surgical Management

TreatmentNotes
HysterectomyONLY definitive cure. Indicated if: Family complete, Severe symptoms refractory to medical management. Can be vaginal, laparoscopic, or abdominal. Ovaries usually conserved if premenopausal.
Excision of AdenomyomaFor focal disease in women desiring fertility. Technically challenging. Risk of uterine rupture in subsequent pregnancy.

8. Complications
ComplicationNotes
AnaemiaFrom chronic heavy bleeding. May require iron supplementation or transfusion.
Reduced Quality of LifePain and bleeding significantly impact daily life.
Infertility / SubfertilityControversial, but may impair implantation.
Complications of TreatmentMirena expulsion, Surgical complications (Hysterectomy: Injury to bladder/ureter/bowel).

9. Prognosis and Outcomes
FactorNotes
Natural HistoryOestrogen-dependent. Symptoms regress after menopause.
Medical ManagementImproves symptoms but does not cure. Symptoms often recur when treatment stops.
HysterectomyCurative. High patient satisfaction rates.

10. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
Heavy Menstrual BleedingNICE NG88 (2018)Mirena IUS as first-line for HMB. Investigation with USS.
AdenomyosisESHRE / JMIGMRI criteria, Management options.

Key Points

  • NICE recommends Mirena IUS as first-line for heavy menstrual bleeding regardless of cause.
  • Endometrial ablation is generally contraindicated in adenomyosis.

11. Patient and Layperson Explanation

What is Adenomyosis?

The lining of your womb (Endometrium) normally grows only on the inside surface. In adenomyosis, this lining tissue has grown INTO the muscle wall of the womb itself. Every month when you have a period, these pockets of tissue inside the muscle also bleed, causing bruising, swelling, and severe pain.

Is it cancer?

No, adenomyosis is entirely benign (Not cancerous). However, it can make life very difficult due to heavy, painful periods.

Will it affect my fertility?

It might make getting pregnant slightly harder, but many women with adenomyosis have successful pregnancies. If fertility is a concern, we can discuss this in detail.

What are the treatment options?

  • Mirena Coil: A hormonal coil placed in the womb. Very effective at reducing bleeding and pain.
  • Hormonal Pills: The Pill or similar medications can help control symptoms.
  • Surgery: If symptoms are severe and you've completed your family, removing the womb (Hysterectomy) is the only complete cure.

Will it go away on its own?

Adenomyosis is driven by oestrogen. After menopause, when oestrogen levels drop, symptoms usually improve or resolve completely.


12. References

Primary Sources

  1. National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management (NG88). 2018. nice.org.uk/guidance/ng88
  2. Vannuccini S, et al. Recent advances in understanding and managing adenomyosis. F1000Res. 2017;6:283. PMID: 28408979.

13. Examination Focus

Common Exam Questions

  1. Classic Patient: "Who typically gets adenomyosis?"
    • Answer: Multiparous woman in her 40s with heavy, painful periods.
  2. Examination Finding: "What does the uterus feel like on examination?"
    • Answer: Enlarged, Soft/Boggy, Tender, Symmetrically enlarged.
  3. MRI Finding: "What is the diagnostic MRI criterion?"
    • Answer: Junctional Zone thickness >12mm.
  4. First-Line Treatment: "What is first-line medical management?"
    • Answer: Mirena IUS (Levonorgestrel-releasing intrauterine system).

Viva Points

  • Why Avoid Ablation?: Ablation treats the surface endometrium only. Adenomyosis is deep in the muscle. Ablation can cause trapped blood (Corneal haematometra) if the JZ is scarred but deep disease persists.
  • Coexistence with Fibroids: Common. MRI helps distinguish adenomyosis from adenomyoma from fibroid.
  • Difference from Fibroids: Fibroids = Discrete, Firm, Well-defined. Adenomyosis = Diffuse, Boggy, Ill-defined.

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-25

At a Glance

EvidenceHigh
Last Updated2025-12-25

Red Flags

  • Post-Menopausal Bleeding (Endometrial Cancer)
  • Severe Anaemia (Hemodynamic Instability)
  • Acute Severe Pain (Ovarian Torsion/Ectopic)

Clinical Pearls

  • **"Boggy Uterus"**: On bimanual examination, the uterus feels soft, tender, and diffusely enlarged (Unlike fibroids which are firm and knobbly).
  • **"Junctional Zone >12mm"**: The MRI hallmark of adenomyosis. The JZ is the inner myometrial layer.
  • **Mirena is First-Line**: Levonorgestrel IUS (Mirena) thins the endometrium and reduces both bleeding and pain.
  • **Hysterectomy is the Only Cure**: Medical management is symptomatic. If family complete and symptoms severe, hysterectomy is definitive.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines